Wernly, S.; Semmler, G.; Völkerer, A.; Rezar, R.; Datz, L.; Radzikowski, K.; Stickel, F.; Aigner, E.; Niederseer, D.; Wernly, B.;
et al. Cardiovascular Risk Assessment by SCORE2 Predicts Risk for Colorectal Neoplasia and Tumor-Related Mortality. J. Pers. Med. 2022, 12, 848.
https://doi.org/10.3390/jpm12050848
AMA Style
Wernly S, Semmler G, Völkerer A, Rezar R, Datz L, Radzikowski K, Stickel F, Aigner E, Niederseer D, Wernly B,
et al. Cardiovascular Risk Assessment by SCORE2 Predicts Risk for Colorectal Neoplasia and Tumor-Related Mortality. Journal of Personalized Medicine. 2022; 12(5):848.
https://doi.org/10.3390/jpm12050848
Chicago/Turabian Style
Wernly, Sarah, Georg Semmler, Andreas Völkerer, Richard Rezar, Leonora Datz, Konrad Radzikowski, Felix Stickel, Elmar Aigner, David Niederseer, Bernhard Wernly,
and et al. 2022. "Cardiovascular Risk Assessment by SCORE2 Predicts Risk for Colorectal Neoplasia and Tumor-Related Mortality" Journal of Personalized Medicine 12, no. 5: 848.
https://doi.org/10.3390/jpm12050848
APA Style
Wernly, S., Semmler, G., Völkerer, A., Rezar, R., Datz, L., Radzikowski, K., Stickel, F., Aigner, E., Niederseer, D., Wernly, B., & Datz, C.
(2022). Cardiovascular Risk Assessment by SCORE2 Predicts Risk for Colorectal Neoplasia and Tumor-Related Mortality. Journal of Personalized Medicine, 12(5), 848.
https://doi.org/10.3390/jpm12050848
